Responsibilities include:Ensuring effective marketing applications (NDS, SNDS, Notifiable Changes) and Clinical Trial Applications in support of development products for serious chronic diseases. Determining which submission procedures to utilize and identifying issues, gaps, options, and mitigations for development plan to ensure optimal and timely submission and approvalInitiating and managing all interactions and relationships with Health Canada for all regulatory submissions. Leading the development of Canadian labels for new chronic disease treatments; understanding clinical study designs and their potential impact on product labels. Participating in review and approval of product advertising and promotional materials for compliance to Canadian requirements Key achievements:Submitted and received approval for NDS for Canada's first Human Glucagon Like Peptide-1 (GLP-1) which was the first full electronic New Drug Submission in Common Technical Document format for company. Coordinated team negotiations with Health Canada on product label. Contributed to launch preparations through marketing promotional reviews.2) obtained first approval in Canada for weight management indication for Human Glucagon Like Peptide-1 (GLP-1)